COVID-19: treatment of early chronic COVID syndrome

R. Bontsevich (Belgorod, Russian Federation), Y. Vovk (Belgorod, Russian Federation), L. Solovyova (Belgorod, Russian Federation), R. Bontsevich (Belgorod, Russian Federation)

Source: Virtual Congress 2021 – COVID - 19 treatments
Session: COVID - 19 treatments
Session type: E-poster
Number: 3674

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Bontsevich (Belgorod, Russian Federation), Y. Vovk (Belgorod, Russian Federation), L. Solovyova (Belgorod, Russian Federation), R. Bontsevich (Belgorod, Russian Federation). COVID-19: treatment of early chronic COVID syndrome. 3674

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt?
Source: Eur Respir J 2004; 24: 1025-1032
Year: 2004



Does the presence of acute on chronic hyperventilation predict response to treatment in patients with chronic idiopathic hyperventilation
Source: Eur Respir J 2003; 22: Suppl. 45, 88s
Year: 2003

Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010


Definition of risk development obstructive syndrome with patients chronic bronchitis (CB)
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001

Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Source: Eur Respir J 2003; 21: 30S-35S
Year: 2003



Acute and chronic cough syndromes differential diagnosis: infections or not?
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



Strategy for early diagnosis and intervention in chronic respiratory disease
Source: Virtual Congress 2020 – Chinese programme 2020: Part I
Year: 2020

Severe asthma: from inflammatory phenotype to treatment
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017


Chronic interstitial lung disease in children: diagnosis and treatment
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016



Severe asthma: approach to diagnosis and treatment
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Adult-onset asthma: is it really different?
Source: Eur Respir Rev 2013; 22: 44-52
Year: 2013



Severe form of croup syndrome - treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 82s
Year: 2002

Progression to a severe form of COVID-19 among patients with chronic respiratory diseases: a French multicentric study.
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Hand-Schuller-Christian syndrome: diagnosis and treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Mechanisms of persistence of Streptococcus pneumoniae following treatment of acute exacerbation of chronic bronchitis
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009


Tourette‘s syndrome manifest as chronic cough in children
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011